arrow-positive PFE - Pfizer Inc Com Usd0.05 29.8 +0.01 (+0.03%)

As of October 27, 2026 4:02 pm EDT
Add to Watchlist
Get new quote

Quote Detail

Last 29.80
Change 0.01
Change % 0.03
Bid 29.76 X 2800
Ask 29.79 X 100
Volume 25.59 M
Shares n.a.
Market Cap n.a.
   
Open 29.54
High 29.86
Low 29.51
Prev Close 29.79
52 Wk High 30.44
52 Wk Low 23.62
EPS n.a.
P/E n.a.
Div Yield n.a.

Market Headlines

Immuno-Oncology Emerges as a Major Force in the Global Cancer Treatment Market 10/26/2026 09:00AM

October 26, 2026 (GLOBE NEWSWIRE via COMTEX News Network) -- NEW YORK, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Cancer treatment is moving into a new phase, and immuno-oncology is right at the center of...

Healthcare Stocks Rushing Higher, with Oncology Push, Breakout Test, and Lilly’s Next Growth Chapter 10/23/2026 02:33AM

October 23, 2026 (GLOBE NEWSWIRE via COMTEX News Network) -- DENVER, Oct. 22, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) — Healthcare stocks are presenting investors with a mix of...

Precision Trading with Pfizer Inc. (PFE) Risk Zones 10/19/2026 06:53PM

Oct 19, 2026 (Stock Traders Daily via COMTEX News Network) -- Analysis for: PFEKey findings for Pfizer Inc. (NYSE: PFE)Near-Term Strong Sentiment Could Influence Mid-Term Neutrality Toward...

Astellas Highlights Data Advancing Cancer Care and Innovation for Patients with Hard-to-Treat Cancers at ESMO 2026 10/06/2026 10:56PM

TOKYO, Oct. 6, 2026 /PRNewswire via COMTEX News Network/ -- PADCEV(TM) (enfortumab vedotin) plus pembrolizumab data highlight durable survival benefit in advanced bladder cancer -

News

X
Close